We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

UK investors are buying Fulgent and Carnival shares, says Fineco

UK investors are looking at the US market for top growth opportunities, according to the latest data from trading platform Fineco.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Buying US shares is easier than ever for UK investors. Share trading platform Fineco says that top US healthcare and pharma stocks were among the most popular with UK investors last week.

Topping the list was biotech company Fulgent Genetics. NASDAQ-listed Fulgent is heavily involved in Covid-19 testing and recently reported a 3,400% increase in quarterly revenue.

Should you buy Fulgent Genetics, Inc. shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Another big trend highlighted by Fineco’s data was the trade in reopening stocks. This included big names in the US and UK travel sectors, such as Carnival and Rolls-Royce.

Here’s my take on the biggest movers reported by Fineco this week.

US shares lead the way

UK traders on Fineco’s platform seem to be spending a lot of their time focusing on fast-moving US stocks. The top five movers last week were all US-listed firms in the pharma and tech sectors.

In first place was Fulgent Genetics. This company specialises in genetic testing that provides clinically actionable information. But it’s Fulgent’s success in Covid-19 testing that has boosted its share price by 760% over the last year.

Fulgent says that revenue rose by 1,200% to $422m in 2020. The firm expects this figure to rise by 90% to $800m in 2021, including $70m from its next generation sequencing genetic testing service.

Fulgent shares are priced on a modest multiple of 8.5 times 2021 forecast earnings, but brokers expect earnings to fall by 70% in 2022 as the Covid-19 pandemic recedes.

Other top US stocks that were heavily traded by Fineco’s UK investor clients last week included vaccine firm Moderna, Regeneron Pharmaceuticals, and China-based tech stocks SOS Ltd and Lizhi Inc.

Two notable names that were out of favour were Airbnb and Germany car stock Volkswagen. Both were sold heavily on the Fineco platform last week.

UK investors buy reopening stocks

What about UK shares? Fineco’s traders showed plenty of interest in their home market too. Reopening stocks led the way. These are companies that are expected to benefit from a return to normal as the UK exits lockdown.

The world’s largest cruise ship operator, Carnival, was one of Fineco’s top UK movers. Other stocks that caught buyers’ interest included The Gym Group and budget airline Wizz Air.

Travel and leisure weren’t the only themes. Gold miners Centamin and Polymetal International both saw strong buying on Fineco. Both of these big producers have reported solid financial results recently.

Centamin’s net profit rose by 78% to $156m last year, while Polymetal’s earnings rose by 125% to $1,086m. The outlook is positive for both businesses, according to their respective CEOs.

Elsewhere, the prospects for housebuilders seemed to divide opinion among Fineco’s UK investors. Investors bought and sold equal volumes of shares in housebuilder Crest Nicholson last week.

Outsourcer Serco Group received a similar split decision, but investors turned cautious on grocer Wm Morrisons Supermarkets. Investors trading the Bradford-based supermarket’s shares sold two shares for every one they bought. I think this weakness could reflect concerns that shoppers will start spending more widely as the economy reopens.

Roland Head owns shares of Polymetal International. The Motley Fool UK owns shares of and has recommended Fulgent Genetics, Inc. The Motley Fool UK has recommended Airbnb, Inc., Moderna Inc., Morrisons, The Gym Group, and Wizz Air Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female couple boarding their plane at the airport to go on holiday.
Investing Articles

Can the Rolls-Royce share price reach £15.97 by the end of August?

The Rolls-Royce share price has had a solid run in the last year. Muhammad Cheema takes a look at whether…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

Up 1,200% in 5 years, here’s why Nvidia could still be a brilliant value stock

An exciting new announcement that could reshape the PC industry has just pushed Nvidia stock... well, just about nowhere really.

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How investing £4.50 a day could set you on the way to a £1,505 monthly second income

How can UK stocks with high dividend yields help investors earn a meaningful second income from the price of a…

Read more »

Investing Articles

Up 103% with a P/E of 261 — is this FTSE 100 stock still worth buying?

One FTSE 100 stock is quietly moving higher while most investors are still looking elsewhere — is the market missing…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

The smart money thinks AI stocks look risky — but is there still a chance to buy?

According to fund managers, the AI trade is getting crowded. But they still seem to think it’s the place to…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Barclays shares are 11% below their 52-week high. Could they be a bit of a bargain to consider?

Overpriced or one of the FTSE 100’s hidden gems? James Beard takes a closer look at how the market is…

Read more »

Stack of one pound coins falling over
Investing Articles

Down 65% but yielding 6.7% – is this beaten-down UK stock now a generational bargain?

Harvey Jones says this UK stock is one of the worst FTSE 100 performers but there are sound reasons to…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Is this FTSE stock really 46% undervalued?

Analysts reckon this FTSE stock should be worth nearly 50% more. James Beard considers why there’s so much positivity surrounding…

Read more »